Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 11 Prostatic Neoplasms 6 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Liver Neoplasms 3 Uterine Cervical Neoplasms 2 Tongue Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Mouth Neoplasms 2 Liver Cirrhosis 2 Kidney Neoplasms 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Urologic Neoplasms 1 Urethral Neoplasms 1 Thoracic Neoplasms 1 Testicular Neoplasms 1 Solid Tumor 1 Renal Colic 1 Rectal Neoplasms 1 Pregnancy, Ectopic 1 Pneumonia 1 Pleural Effusion 1 Phlebitis 1 Penile Neoplasms 1 Mesothelioma 1 Melanoma 1 Margins of Excision 1 Lymphoma, Primary Effusion 1

Interventions

Carboplatin 15 Pemetrexed 8 Paclitaxel 6 pembrolizumab 5 osimertinib 4 atezolizumab 4 Gemcitabine 4 Erlotinib Hydrochloride 4 entinostat 3 durvalumab 3 Cisplatin 3 selpercatinib 2 pralsetinib 2 camrelizumab 2 apatinib 2 Vinorelbine 2 Radiosurgery 2 Nivolumab 2 Injections 2 Gefitinib 2 Bevacizumab 2 130-nm albumin-bound paclitaxel 2 toripalimab 1 sotorasib 1 sintilimab 1 repotrectinib 1 pegylated granulocyte colony-stimulating factor 1 patritumab 1 necitumumab 1 napabucasin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Thoracic Neoplasms × Ultrasonography × Clear all

NCT05321615 2023-10-25

Palpator

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Unknown

Lung Neoplasms, Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡